AHF Turns Spotlight on Pharmaceutical Greed

AHF starts a nationwide advocacy campaign to highlight corporate greed and the exorbitant price of Gilead Science’s Hepatitis C drug Sovaldi, which goes for $1,000 per pill. The wildly expensive medication prevents wide access to the life-saving treatment.